Ezenide Lotion 0.05% ww

Kraj: Malezja

Język: angielski

Źródło: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Składnik aktywny:

DESONIDE

Dostępny od:

HOE PHARMACEUTICALS SDN. BHD.

INN (International Nazwa):

DESONIDE

Sztuk w opakowaniu:

30gm mcg/mL; 30 ml mL

Wyprodukowano przez:

HOE PHARMACEUTICALS SDN. BHD.

Ulotka dla pacjenta

_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
1
EZENIDE LOTION
Desonide (0.05% w/w)
_ _
WHAT IS IN THIS LEAFLET
1.
What Ezenide Lotion is used for
2.
How Ezenide Lotion works
3.
Before you use Ezenide Lotion
4.
How to use Ezenide Lotion
5.
While
you
are
using
Ezenide
Lotion
6.
Side effects
7.
Storage and disposal of Ezenide
Lotion
8.
Product description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
This leaflet answers some common
questions about Ezenide Lotion. It
does
not
contain
all
the
available
information.
It
does
not
take
the
place of talking to your pharmacist
or doctor.
IF
YOU
HAVE
ANY
CONCERNS
ABOUT
TAKING
THIS
MEDICINE,
ASK
YOUR
PHARMACIST OR DOCTOR.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT EZENIDE LOTION IS USED FOR
Ezenide Lotion is used to suppress
skin disease in which inflammation
and
itching
are
the
prominent
features.
These
skin
problems
do
respond to corticosteroids.
HOW EZENIDE LOTION WORKS
Ezenide Lotion contains a medicine
called desonide. It belongs to a group
of medicines called steroids. It is a
topically
active,
nonfluorinated
corticosteroid
which
has
anti-
inflammatory, anti-itching and blood
vessels constricting actions.
BEFORE YOU USE EZENIDE LOTION _ _
_ _
_- When you must not use it _
DO NOT USE EZENIDE LOTION:
If you are allergic (hypersensitive) to
desonide,
other
corticosteroids,
or
any
components
in
the
base
of
Ezenide Lotion.
_- Before you start to use it _
Tell your pharmacist or doctor:
If you are applying the lotion under
an
airtight
dressing,
including
a
child’s nappy. These dressings make
it easier for the active ingredient to
pass through the skin. It is possible
to
accidentally
end
up
using
too
much lotion.
If
you
are
not
sure
if
any
of
the
above applies to you, talk to your
doctor
or
pharmacist
before
using
this medicine.
PREGNANCY AND BREAST FEEDING:
Ask your doctor or pharmacist for
advice before taking this medicine if
you are pregnant or breast-feeding.
The safety of using Ezenide Lotion
during pregnancy

Charakterystyka produktu

EZENIDE LOTION 0.05% W/W
Date edited : 20-11-2020
Paper : white simili 70gsm
NAME AND STRENGTH OF ACTIVE SUBSTANCE: Desonide 0.05% w/w.
PRODUCT DESCRIPTION: Off-white opaque viscous lotion with
characteristic odour.
Other ingredients are Disodium Edetate, Citric Acid Anhydrous, Xanthan
Gum, Sodium Benzoate,
Disodium Hydrogen Phosphate Dihydrate, Saccharide lsomerate,
Polysorbate 60, Cetostearyl
Alcohol, Sorbitan Monostearate, Macrogol 400, Squalane and Purified
Water.
PHARMACODYNAMICS: Desonide is a topically active, nonfluorinated
corticosteroid which has
anti-inflammatory, antipruritic and vasoconstrictive actions.
PHARMACOKINETICS: Corticosteroids are extensively bound to plasma
proteins. Only unbound
corticosteroids have pharmacological effects or are metabolised. They
are metabolised mainly in
the liver and also in the kidney, and are excreted in the urine.
INDICATIONS: For the relief of inflammatory and pruritic manifestation
of corticosteroid-
responsive dermatoses.
CONTRAINDICATIONS: Hypersensitivity to Desonide, other
corticosteroids, or any component in
the base.
ADVERSE EFFECTS: Reported local adverse reactions are burning
sensation, itching, irritation,
dryness, folliculitis, hypertrichosis, acneiform eruptions,
hypopigmentation, maceration of the
skin, secondary infection, skin atrophy, striae and miliaria.
PRECAUTIONS/WARNINGS: Discontinue use if irritation, sensitivity or
other reaction develops and
institute appropriate treatment. Corticosteroid applied to the skin
can be absorbed in sufficient
amount to produce systemic effects such as
hypothalamic-pituitary-adrenal axis suppression,
manifestation of Cushing's syndrome, hyperglycaemia and glucosuria.
Thus suitable precautions
should be taken during prolonged treatment, when treating extensive
body surface areas, when
using the occlusive technique and when treating children (because of a
larger skin surface area
to bodyweight ratio). The safety of using topical corticosteroids
during pregnancy and lactation
has not been established.
ROUTE OF ADMIN